LifeMD logo
LifeMD LFMD
$ 3.45 -4.43%

Quarterly report 2025-Q3
added 11-17-2025

report update icon

LifeMD Financial Statements 2011-2025 | LFMD

Annual Financial Statements LifeMD

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

270 M 37.8 M 105 M 297 M 6.43 M 7.07 M 11.7 M 8.37 M 4.62 M 5.47 M 7.93 M 4.68 M 3.81 M

Shares

33.9 M 31 M 27 M 14.3 M 9.9 M 8.84 M 8.35 M 6.7 M 6.16 M 6.07 M 5.88 M 5.5 M 4.48 M

Historical Prices

7.95 1.22 3.87 6.53 0.6 0.7 1.7 1.3 0.6 0.5 1.3 0.8 1

Net Income

-20.6 M -45.5 M -60.9 M -58.6 M -3.14 M -1.24 M -1.21 M -1.11 M -62 K -460 K -268 K -446 K -503 K

Revenue

153 M 119 M 92.9 M 37.3 M 12.5 M 8.32 M 5.05 M 5.24 M 1.22 M 714 K 808 K 674 K 744 K

Cost of Revenue

18.9 M 18.7 M 18 M 8.86 M 2.53 M 2 M 1.02 M 1.95 M 248 K 173 K 181 K 200 K -

Gross Profit

134 M 100 M 74.9 M 28.4 M 9.2 M 6.36 M 3.57 M 3.29 M 971 K 541 K 627 K 548 K 503 K

Operating Income

-14.5 M -43.4 M -54.3 M -57.8 M -2.89 M -2.06 M -1.23 M -1.17 M -262 K -531 K -546 K -540 K -

Interest Expense

2.6 M 1.28 M 3.02 M 1.67 M 761 K 354 K 101 K 48.6 K 37.5 K 4.68 K 3.38 K 3.37 K -

EBITDA

-14.3 M -43.3 M -54.3 M -57.4 M -2.55 M -1.86 M -1.07 M -1.17 M -218 K -474 K -489 K -483 K -520 K

Operating Expenses

148 M 144 M 129 M 86.2 M 12.1 M 8.41 M 4.64 M 4.47 M 1.23 M 1.07 M 1.17 M 1.09 M 1.08 M

General and Administrative Expenses

51.7 M 47 M 39.5 M 42.2 M 2.4 M 3.33 M 2.98 M 2.76 M 979 K 1.07 M 1.17 M 1.09 M -

All numbers in USD currency

Quarterly Income Statement LifeMD

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

46.2 M 44.4 M 43.1 M 42.2 M 42 M 41.3 M 39.2 M 38.3 M 34.5 M 32.6 M 31.7 M 31.4 M 30.9 M 30.8 M 30.9 M 30.6 M 26.7 M 26.3 M 24.5 M 23.3 M 14.7 M 12.3 M 10.7 M 10.6 M 10.1 M 46.9 M 46.8 M 45.3 M 44.4 M 44.4 M 43.5 M 44 M 40.8 M 40.8 M 37.6 M 35.2 M 34.4 M 32.3 M 32 M 32 M 30.6 M - 30.7 M 30.7 M 30.3 M - 30.2 M 30.1 M 29.4 M 29.2 M 28.9 M 28.9 M 28.9 M 27.6 M 24.7 M - - - -

Net Income

-3.81 M -2.07 M 1.38 M - -4.66 M -6.88 M -6.77 M - -6.12 M -6.73 M -4.01 M - -7.28 M -13 M -13.3 M - -14.4 M -17 M -11.9 M - -20.6 M -3.38 M -2.39 M - -944 K -818 K -664 K - -496 K -1.05 M 627 K - -679 K 737 K -1.04 M - -227 K -200 K -62 K - 8.12 K -21 K 1.67 K - -104 K -71.5 K -141 K - -139 K -15.9 K -41.5 K - -159 K -187 K -28.3 K - - - -

Revenue

60.2 M 62.2 M 65.7 M - 53.3 M 50.7 M 44.1 M - 38.6 M 35.9 M 33.1 M - 31.4 M 30.5 M 29 M - 24.9 M 22.3 M 18.2 M - 11 M 9.09 M 4.3 M - 3.13 M 2.7 M 2.7 M - 2.5 M 2.04 M 1.61 M - 2.05 M 660 K 5 M - 1.38 M 1.23 M 1.64 M - 280 K 277 K 288 K - 165 K 197 K 192 K - 94.7 K 323 K 230 K - 152 K 228 K 179 K - - - -

Cost of Revenue

7.41 M 7.43 M 8.64 M - 5.01 M 5.02 M 4.6 M - 4.78 M 4.55 M 4.21 M - 4.72 M 4.64 M 5.25 M - 5.1 M 4.12 M 3.21 M - 1.68 M 1.69 M 1.34 M - 680 K 655 K 712 K - 440 K 535 K 355 K - 536 K 185 K 88.2 K - 388 K 701 K 1.34 M - 74 K 89.5 K 74.2 K - 71.6 K 69.2 K 49.1 K - 42.4 K 65.7 K 52.9 K - 53.9 K 104 K 29.6 K - - - -

Gross Profit

52.8 M 54.8 M 57.1 M - 48.3 M 45.6 M 39.5 M - 33.8 M 31.4 M 28.9 M - 26.7 M 25.8 M 23.8 M - 19.9 M 18.2 M 15 M - 9.33 M 7.4 M 2.97 M - 2.45 M 2.04 M 1.99 M - 2.06 M 1.5 M 1.25 M - 1.52 M 475 K 79.7 K - 996 K 526 K 303 K - 206 K 188 K 214 K - 93.9 K 127 K 143 K - 52.3 K 257 K 177 K - 98.3 K 124 K 149 K - - - -

Operating Income

-1.97 M -907 K 2.54 M - -4 M -6.31 M -6.17 M - -4.57 M -4.9 M -2.85 M - -7.07 M -12.9 M -13.1 M - -12.6 M -16.1 M -11.9 M - -20.5 M -3.22 M -1.74 M - -974 K -833 K -563 K - -386 K -938 K -279 K - -274 K -380 K -402 K - -208 K -154 K -105 K - 17.9 K -17.2 K 7.83 K - -133 K -75.4 K -178 K - -169 K -20.2 K -70.8 K - -164 K -216 K -35.8 K - - - -

Interest Expense

262 K 663 K 626 K - 559 K 531 K 478 K - 714 K 996 K 264 K - 132 K 132 K 168 K - 1.82 M 902 K 139 K - 291 K 229 K 793 K - 131 K 130 K 170 K - 148 K 148 K 6.45 K - 1.11 K 250 649 K - 9.99 K 2.75 K 3.06 K - 14.4 K 8.16 K 10.5 K - 259 428 478 - - - - - - 443 2.93 K - - - -

EBITDA

-1.7 M -646 K 2.71 M - -3.75 M -6.06 M -6.11 M - -4.32 M -4.65 M -2.81 M - -6.74 M -12.7 M -13.1 M - -12.6 M -15.9 M -11.8 M - -20.4 M -3.13 M -1.66 M - -890 K -749 K -479 K - -344 K -938 K -279 K - -274 K -380 K -402 K - -208 K -154 K -105 K - 61.7 K 11.3 K 22.1 K - -90.2 K -46.9 K -163 K - -126 K 8.33 K -56.5 K - -121 K -187 K -21.7 K - - - -

Operating Expenses

54.7 M 55.7 M 54.5 M - 52.3 M 51.9 M 45.7 M - 38.4 M 36.3 M 31.8 M - 33.8 M 38.7 M 36.9 M - 32.4 M 34.3 M 26.9 M - 29.9 M 10.6 M 4.71 M - 3.42 M 2.88 M 2.55 M - 2.44 M 2.44 M 1.53 M - 1.79 M 855 K 482 K - 1.2 M 680 K 408 K - 188 K 205 K - - - - - - - - - - - - - - - - -

General and Administrative Expenses

16.6 M 10.9 M 17.1 M - 18.1 M 8.24 M 15.3 M - 13.4 M 12.1 M 10.6 M - 12.4 M 13.2 M 12.2 M - 10.7 M 20.9 K 7.02 M - 18.4 M 1.83 M 1.59 M - 929 K 373 K 478 K - 301 K 301 K 357 K - 278 K 319 K 108 K - 205 K 79.5 K 98.4 K - 57.6 K 63.9 K 85.3 K - 43.3 K 62.8 K 102 K - 98.7 K 82.3 K 81.5 K - 85.4 K 89.1 K 90.8 K - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements LifeMD LFMD
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting LifeMD plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Pharmaceutical retailers industry

Issuer Price % 24h Market Cap Country
Аптеки 36.6 Аптеки 36.6
APTK
- - - russiaRussia
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.
CJJD
- -5.59 % $ 49.9 M chinaChina
Greenlane Holdings Greenlane Holdings
GNLN
$ 2.99 -3.24 % $ 22.5 M usaUSA
BOQI International Medical BOQI International Medical
BIMI
- 6.33 % $ 5.86 M chinaChina
Trxade Group Trxade Group
MEDS
- 4.55 % $ 5.8 M usaUSA
PetMed Express PetMed Express
PETS
$ 3.02 70.69 % $ 62.2 M usaUSA
Rite Aid Corporation Rite Aid Corporation
RAD
- - $ 35.5 M usaUSA
111 111
YI
$ 3.7 -4.15 % $ 636 M chinaChina
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
- - $ 10.3 B usaUSA